CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: FDA takes another look at botanical drugs

RegulatoryNeutral
AI Analysis

Summary

FDA is conducting additional review of botanical drugs. Ionis Pharmaceuticals reported its first approval for an Alexander disease treatment amid industry regulatory scrutiny.

Outcome Details

FDA reviewing botanical drugs

Importance:3/10
Sentiment:
0.00
FDAregulatorybotanical drugsschizophreniaAlexander diseaseIonis approval
Related Companies

Read the original article

Published by STAT News on September 4, 2026 1:46 PM

Read Original